TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2019

Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study.

Anish Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.